Olio Labs


Developer of an integrated discovery-and-validation platform that combines computational models trained on curated human clinical-outcome data with a high-throughput automated in vivo behavioral phenotyping system to prioritize and validate combination therapeutic hypotheses.

Industries

Artificial Intelligence
Artificial Intelligence (AI)
Biopharma
Biotechnology
Machine Learning
Therapeutics
Biotechnology Research

Nr. of Employees

small (1-50)

Olio Labs

South San Francisco, California, United States


Products

Automated in vivo phenomics platform (home-cage PAD array)

Hardware and software system that records continuous rodent behavior across many cages in parallel, extracts pose and action features, and supports multivariate behavioral analyses.

Combination-design computational engine

Modeling engine that predicts therapeutic profiles (efficacy, safety, tolerability) for single agents and combinations and ranks candidates for validation.


Services

Software platform that models interacting biological layers to infer and rank therapeutic target combinations conditioned on biological covariates.

Parallel automated rodent behavioral screening service that converts 24-hour behavioral recordings into predictions of human efficacy, tolerability, and toxicity.

Extraction and normalization of clinical-trial and registry data using agentic pipelines with expert verification for model-ready datasets.

Expertise Areas

  • Combination-therapy discovery
  • Preclinical behavioral phenomics
  • Cross-species translational modeling
  • Automated home-cage monitoring
  • Show More (4)

Key Technologies

  • Automated home-cage phenotyping (96-parallel PADs)
  • Computer vision and pose estimation
  • Behavioral feature extraction and engineering
  • Agent-driven document extraction and normalization
  • Show More (4)

News & Updates

Blog post discussing how human observation affects biomedical research and clinical translation.

Technical manuscript describing the in vivo validation platform and methods for mapping rodent behavior to human outcomes.

Manuscript reporting that brief human health checks transiently mask drug-induced behavioral phenotypes in mice, assessed using a continuous home-cage monitoring platform.

Manuscript analyzing sex differences in GLP-1 signaling and side-effect profiles across species.

Company profile on a startup launch site describing use of AI to develop combination therapeutics.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.